CG
Colin Goddard
Director

Colin Goddard insider trades: Human Genome Sciences (HGSI) stock buys and sales

Director, Human Genome Sciences Last trade Aug 4, 2011 31 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2006
3
Companies
last trade 2011

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Colin reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 4, 2011HGSI↑ Buy$49K
Mar 22, 2011HGSI↑ Buy$75K
Mar 1, 2010OSIP↓ Sell$3.6M
Jun 4, 2007OSIP↓ Sell$1.5M
Aug 25, 2006OSIP↓ Sell$982K
Aug 25, 2006OSIP↓ Sell$100K
Jun 2, 2006OSIP↓ Sell$723K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Colin Goddard's insider trades

Colin Goddard is a director at Human Genome Sciences (HGSI). Since Jun 2, 2006, Colin has reported 2 open-market purchases worth $123K and 5 sales worth $7.0M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (17 filings), option exercises (5 filings), shares withheld for taxes (5 filings), shares returned to the company (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HGSI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.